These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26808969)

  • 1. Location, location, location: PDE4D5 function is directed by its unique N-terminal region.
    Wills L; Ehsan M; Whiteley EL; Baillie GS
    Cell Signal; 2016 Jul; 28(7):701-5. PubMed ID: 26808969
    [No Abstract]   [Full Text] [Related]  

  • 2. Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains.
    Bolger GB; Dunlop AJ; Meng D; Day JP; Klussmann E; Baillie GS; Adams DR; Houslay MD
    Cell Signal; 2015 Apr; 27(4):756-69. PubMed ID: 25546709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyclic AMP phosphodiesterase 4D5 (PDE4D5)/receptor for activated C-kinase 1 (RACK1) signalling complex as a sensor of the extracellular nano-environment.
    Yarwood SJ; Parnell E; Bird RJ
    Cell Signal; 2017 Jul; 35():282-289. PubMed ID: 28069443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of cAMP-phosphodiesterase 4D7 (PDE4D7) is regulated by protein kinase A-dependent phosphorylation within its unique N-terminus.
    Byrne AM; Elliott C; Hoffmann R; Baillie GS
    FEBS Lett; 2015 Mar; 589(6):750-5. PubMed ID: 25680530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of RAID1, the RACK1 interaction domain located within the unique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5.
    Bolger GB; McCahill A; Yarwood SJ; Steele MR; Warwicker J; Houslay MD
    BMC Biochem; 2002 Aug; 3():24. PubMed ID: 12193273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-induced iNOS and ERK1/2 inhibit adenylyl cyclase type 5/6 activity and stimulate phosphodiesterase 4D5 activity in intestinal longitudinal smooth muscle.
    Mahavadi S; Nalli AD; Kumar DP; Hu W; Kuemmerle JF; Grider JR; Murthy KS
    Am J Physiol Cell Physiol; 2014 Aug; 307(4):C402-11. PubMed ID: 24944202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory phosphorylation of cAMP-specific PDE4D5 by contractile agonists is mediated by PKC-dependent inactivation of protein phosphatase 2A.
    Murthy KS; Sriwai W
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G327-35. PubMed ID: 18006600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE4D phosphorylation: A coincidence detector integrating multiple signaling pathways.
    Mika D; Conti M
    Cell Signal; 2016 Jul; 28(7):719-24. PubMed ID: 26562185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5.
    Bolger GB; Baillie GS; Li X; Lynch MJ; Herzyk P; Mohamed A; Mitchell LH; McCahill A; Hundsrucker C; Klussmann E; Adams DR; Houslay MD
    Biochem J; 2006 Aug; 398(1):23-36. PubMed ID: 16689683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial.
    Baillie GS
    Cell Signal; 2016 Jul; 28(7):699-700. PubMed ID: 26850139
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of murine cardiac function by phosphodiesterases type 3 and 4.
    Beca S; Aschars-Sobbi R; Panama BK; Backx PH
    Curr Opin Pharmacol; 2011 Dec; 11(6):714-9. PubMed ID: 22047792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B.
    Johanns M; Lai YC; Hsu MF; Jacobs R; Vertommen D; Van Sande J; Dumont JE; Woods A; Carling D; Hue L; Viollet B; Foretz M; Rider MH
    Nat Commun; 2016 Mar; 7():10856. PubMed ID: 26952277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling.
    Houslay MD; Baillie GS; Maurice DH
    Circ Res; 2007 Apr; 100(7):950-66. PubMed ID: 17431197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unique amino-terminal region of the PDE4D5 cAMP phosphodiesterase isoform confers preferential interaction with beta-arrestins.
    Bolger GB; McCahill A; Huston E; Cheung YF; McSorley T; Baillie GS; Houslay MD
    J Biol Chem; 2003 Dec; 278(49):49230-8. PubMed ID: 14500724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter.
    Le Jeune IR; Shepherd M; Van Heeke G; Houslay MD; Hall IP
    J Biol Chem; 2002 Sep; 277(39):35980-9. PubMed ID: 12121997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p62 (SQSTM1) forms part of a novel, reversible aggregate containing a specific conformer of the cAMP degrading phosphodiesterase, PDE4A4.
    Houslay MD; Christian F
    Autophagy; 2010 Nov; 6(8):1198-200. PubMed ID: 20864809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H NMR structural and functional characterisation of a cAMP-specific phosphodiesterase-4D5 (PDE4D5) N-terminal region peptide that disrupts PDE4D5 interaction with the signalling scaffold proteins, beta-arrestin and RACK1.
    Smith KJ; Baillie GS; Hyde EI; Li X; Houslay TM; McCahill A; Dunlop AJ; Bolger GB; Klussmann E; Adams DR; Houslay MD
    Cell Signal; 2007 Dec; 19(12):2612-24. PubMed ID: 17900862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase-4D Knock-down in the Prefrontal Cortex Alleviates Chronic Unpredictable Stress-Induced Depressive-Like Behaviors and Memory Deficits in Mice.
    Wang ZZ; Yang WX; Zhang Y; Zhao N; Zhang YZ; Liu YQ; Xu Y; Wilson SP; O'Donnell JM; Zhang HT; Li YF
    Sci Rep; 2015 Jul; 5():11332. PubMed ID: 26161529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheb Inhibits Beiging of White Adipose Tissue via PDE4D5-Dependent Downregulation of the cAMP-PKA Signaling Pathway.
    Meng W; Liang X; Chen H; Luo H; Bai J; Li G; Zhang Q; Xiao T; He S; Zhang Y; Xu Z; Xiao B; Liu M; Hu F; Liu F
    Diabetes; 2017 May; 66(5):1198-1213. PubMed ID: 28242620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
    Collins DM; Murdoch H; Dunlop AJ; Charych E; Baillie GS; Wang Q; Herberg FW; Brandon N; Prinz A; Houslay MD
    Cell Signal; 2008 Dec; 20(12):2356-69. PubMed ID: 18845247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.